Asthma management, education and environmental interventions have been reported as cost-effective in a previous review (Pharm Pract (Granada), 2014;12:493), but methods used to estimate costs and outcomes were not discussed in detail. This review updates the previous review by providing economic evidence on the cost-effectiveness of studies identified after 2012, and a detailed assessment of the methods used in all identified studies. Twelve databases were searched from 1990 to January 2016, and studies included economic evaluations, asthma subjects and nonpharmacological interventions written in English. Sixty-four studies were included. Of these, 15 were found in addition to the earlier review; 53% were rated fair in quality and 47% high. Education and self-management interventions were the most cost-effective, in line with the earlier review. Self-reporting was the most common method used to gather resource-use data, accompanied by bottom-up approaches to estimate costs. Main outcome measures were asthmarelated hospitalizations (69%), quality of life (41%) and utility (38%), with AQLQ and the EQ-5D being the most common questionnaires measured prospectively at fixed time points. More rigorous costing methods are needed with a more common quality of life tool to aid greater replicability and comparability amongst asthma studies.
2012 until January 2016, and the extension identifies, describes and assesses the array of methods used in estimating and evaluating both costs and outcomes for economic analyses from 1990 to January 2016. The protocol for this review was registered with PROS-PERO International Prospective Register of Systematic Reviews with registration number: CRD42016032963.
2 | ME TH ODS 2.1 | Eligibility criteria
| Study design
Original research articles were considered for inclusion. These were defined as an economic evaluation: cost-effectiveness analysis (CEA), cost utility analysis (CUA), cost benefit analysis (CBA) or a cost consequences analysis (CCA). Other types of economic studies were excluded, alongside letters, editorials, magazines, conference abstracts and reviews.
| Population
Participants with different severities of asthma of any age and from any country were included.
| Intervention and comparators
Nonpharmacological asthma interventions were included, such as educational, environmental or self-management interventions. Comparators of pharmacological, nonpharmacological or usual care alternatives were permitted.
| Outcomes
The primary outcomes were to identify the incremental cost-effectiveness ratios (ICERs) and net benefit results to compare the costeffectiveness results in all studies found from the updated search.
The secondary outcomes were to identify the effectiveness and monetary outcomes (eg, willingness to pay) to explore how they were evaluated across all included studies.
| Search strategy
A comprehensive database search was conducted (search terms; Appendix S1), including databases searched from Yong and Shafie 3 and additional databases to ensure all relevant databases were searched. The included databases searched are as follows: ScienceDirect, Wiley Online Library, EbscoHost, Embase (via OvidSP), Medline (via OvidSP) and Scopus, and additional databases: CINAHL (via EbscoHost), Cochrane (CENTRAL), NHS Economic Evaluation Database (NHS EED), ClinicalTrials.gov, ProQuest and Open Grey. The latter 3 databases were included to identify any unpublished literature. Truncation and phrase searching were used for an inclusive search and to retrieve papers that included the specific quoted phrases. All databases were restricted to the English language only with searches from 1990 until January 2016.
| Study selection
All studies retrieved from the database search were transferred into EndNote software manager, with duplicates removed. All titles and abstracts were independently screened for eligibility by 1 reviewer (CJCB) and then second reviewers (AP, RFSK). Full texts of included articles were assessed for eligibility, and if any uncertainties arose, then discussions between 2 reviewers occurred (CJCB, AP or CJCB, RFSK) with a third reviewer required if there were any discrepancies (RFSK, AP).
| Data extraction
Data were extracted from included studies into a predesigned table (Appendix S2) by 1 independent reviewer (CJCB) with second reviewers (AP, RFSK) confirming accuracy and discussing any discrepancies.
| Quality assessment
Two quality assessment checklists were used in this review: Quality of Health Economic Studies (QHES) (Appendix S3) adapted by Yong and Shafie, 3 but originally designed by Chiou et al, 8 and the Philips et al's 9 criteria for model-based studies. Quality assessment occurred independently by 1 reviewer (CJCB), with second reviewers (AP, RFSK) checking for accuracy and resolving any discrepancies through discussion.
| RESULTS
The extensive search retrieved 2118 studies. After duplicates were removed (287), a further 1715 studies were excluded from the title and abstract screening. After reviewing the full texts of the remaining studies, 64 studies were included for analysis (Figure 1) . Of the 64, 15 studies were found in addition to Yong and Shafie. 
| Population
Population groups chosen were mostly children-focused [10] [11] [12] [16] [17] [18] [19] [20] 22, 23 with 1 adult-only study, 21 and combination of the 2. A wide selection of health questionnaires were used to collect data in the studies (Figure 2) , mostly by patient self-report, but often in conjunction with face-to-face visits 12 [64] [65] [66] [67] -were the most commonly used. The studies that used the EQ-5D and Short Form-6 Dimension (SF-6D) 15 converted the scores into utility values and used these to estimate quality-adjusted life years (QALYs). Other studies that did not estimate QALYs used total and/or overall mean scores from the health questionnaires in their analysis.
| DISCUSSION
This systematic review updated and extended a previous study that evaluated the cost-effectiveness of nonpharmacological asthma interventions with databases searched from 1990 until 2012. 3 The extension included extending this database search until January 2016, and the update included an assessment of the methods used to estimate both costs and outcomes in all studies found from 1990 until 2016.
| Main findings
In line with the findings from Yong and Shafie, 3 the additional education and self-management study-based interventions found in this review were deemed most cost-effective or dominant. The quality of studies has since improved with the additional studies presenting with fair (50%-74%) to high (>74%) quality. Multiple methods were often used to gather resource-use data with selfreport being the most common, the bottom-up approach being the most common estimation method of resource use gathered, and health-related questionnaires being a common outcome measure with AQLQ and EQ-5D being the most common HRQOL questionnaires.
| Comparison with other studies
Earlier systematic reviews of asthma interventions also highlighted the importance of the quality assessment in studies. 5, 6, 72, 73 One study, in particular, believed their peak flow monitoring intervention was cost-effective, but could not conclude this due to the study qualities being so low. 72 This review shows that the quality of studies has much improved since then, with nearly 50% of the studies found post-2012 presenting with high quality.
Although improvement has been noticed in the quality of the studies, some still have an inadequate follow-up, which can reduce validity and generalizability. 74 It was previously acknowledged that a short time horizon was inadequate for chronic conditions, 6 with a time horizon of 3 months or less considered to be unacceptable. 4 The additional studies found in this review presented with 1 study having a time horizon of 3 months, 10 and others longer at between 6 months and 10 years.
As different cost perspectives are used amongst the included studies in this review, it becomes difficult to compare the total costs associated with each intervention. An earlier review noted that the author's definitions of direct medical costs, direct nonmedical costs and indirect costs sometimes varied, where costs assigned to direct nonmedical costs should have been assigned to indirect costs. 72 Previous literature discusses that a societal perspective is important to synthesize the evidence and gain a proper understanding on peak flow monitoring interventions. 72, 75, 76 However, perspectives chosen can differ from country to country and the definitions of a societal perspective can also vary.
It was surprising that only about a quarter of papers included lost productivity as an outcome measure. Due to asthma being a CROSSMAN-BARNES ET AL. In all of the included studies in this review, the intervention details were often reported, but the details surrounding the costs of conducting the interventions with the associated unit costs were limited. Three studies provided comprehensive details about how they estimated the intervention, including the breakdown of the intervention components, their associated unit costs and the methods chosen to estimate such costs. 15, 29, 55 The common approach between all 3 was a microcosting approach. Difficulties can sometimes occur with this approach when prices for certain resources are not always available from various data sources, leaving room for customization. 
| 1191
From the 26 studies that also incorporated quality of life as an outcome measure, there were over 20 different questionnaires that were used to measure this. Many of the questionnaires used to analyse quality of life were more specific to asthma, but there did not appear to be a preferred measure that was used across the studies.
The EQ-5D-3L questionnaire (5 dimensions with 3 levels: no problems, moderate problems and extreme problems) was used across a number of studies, but often used alone and not in conjunction with another quality of life questionnaire. As discussed by Yong and Shafie, 3 EQ-5D-3L might not be the best tool to use for quality of life in asthma, as it is not seen as sensitive enough to detect differences in HRQOL particularly in people with mild asthma. However, there have been recent developments of a new EQ-5D-5L questionnaire, which includes the same 5 dimensions but with 5 levels: no problems, slight problems, moderate problems, severe problems or extreme problems. 79 The newly developed EQ-5D-5L tool may be more suitable as it was designed to be more sensitive and reduce the high ceiling effects. This has been confirmed in several studies that have shown increased reliabilities, sensitivities and validities. terms of increased sensitivities and validities compared to the EQ-5D-3L, due to it being a relatively new questionnaire, it may be advisable to use this in conjunction with a more established diseasespecific questionnaire. Due to the difficulties that arise in economic evaluations and to ensure the comparability across different countries and decision-makers, 81 it may be useful to adhere to an international reference case, which is a useful guide from the planning stages of research through to reporting findings and completion.
Future research should also ensure that the appropriate guidelines and checklists are adhered to, such as the TiDieR checklist, 82 the CHEERS statement, 83 CONSORT statement 84 and the COMET initiative 85 for ease of replicability of both the intervention and control groups by clinicians or researchers looking to implement or expand research ideas, respectively. This will in turn aid the comparability of studies.
| Strengths and limitations
The strength of this review is that it provides a comprehensive synthesis of studies from an extensive database search with studies analysed from 12 databases. The included studies help to understand how asthma interventions and methodologies chosen have evolved over the years, with discussions leading to recommendations for future practice. Bias has been reduced during this review by including 2 independent reviewers during the systematic review process.
However, a limitation of this review is that only English language studies were included, with restrictions of this placed during the database search. Therefore, we are unable to acknowledge how many non-English studies have been excluded from this review, but it is apparent that due to this selection bias, additional studies may have been relevant for inclusion in this review.
| CONCLUSION S
The additional 15 studies identified were of fair to high quality. Most of the additional studies found had dominant or cost-effective interventions that were educational or management based, which mirrored the previous review. The methods used to estimate costs and outcomes varied, with the bottom-up approach being the most common approach; however, the reporting of unit costs was lacking amongst some studies, with only a few studies providing detailed microcosting methodologies for the intervention components. For future studies, a thorough description of methods used in all components of the study is needed, including reporting of unit costs and a common quality of life measure to provide more comparability.
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